4Schurig GG,Sriranganathan N.Corbel MJ.Brucellosis vaccines:past,present and future.Vet Microbiol,2002,90 (1-4):479-496.
5Vemulapalli R,McQuiston JR.,Schurig GG,et al.Identification of and IS7ll element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains.Clin Diagn Lab Immuno,1999,6:760-764.
6Godfroid F,Cloeckaert A,Taminiau B,et al.Genetic organisation of the lipopolysaccharide O-antigen biosynthesis region of Brucella melitensis 16M (wbk).Res Microbiol,2000,151(8):655-668.
7Allen CA,Adams LG,Ficht TA.Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival.Infect Immun,1998,66:1008-1016.
8Godfroid F,Taminiau B,Danese I,et al.Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages.Infect Immun,1998,66:5485 -5493.
9McQuiston JR,Vemulapalli R,Inzana TJ,et al.Genetic characterization of a Tn5-disrupted glycosyltransferase gene homologue in Brucella abortus and its effect on lipopolysaccharide composition and virulence.Infect Immun,1999,67:3830-3835.
10Vemulapalli R,He Y,Buccolo LS,et al.Complementation of rucella abortus RB51 with a functional wboA gene results in Oantigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation.Infect Immun,2000,68:3927-3932.
